Français
English
العربية
Deutsch

Home
Blog
Management
Admin Details
Client Area
Documents
Exclusive Deal
FAQs
Podcast
Products
Tutorial
Job Vacancies

Allergan

01/02/2014

Allergan – Introduction

AGN has strong fundamentals and a diversified revenue base. Its EPS growth is above average.

Link to principal company report: AGN

Related articles

AbbVie Inc

07/07/2025

AbbVie Inc. is a U.S.-based global biopharmaceutical company, spun off from Abbott Laboratories in 2013. Headquartered in North Chicago, Illinois, AbbVie focuses on innovative research, development, and commercialization of advanced...

Allergan – A beauty contest! – Part 1

16/08/2013

Description: Allergan (AGN) is a global specialty pharmaceutical company with head-offices in Irvine, California, USA. Its annual sales amount to about USD 5.9 billion. The company develops, manufactures and markets...

Allergan – A beauty contest! – Part 2

16/08/2013

Company profile, investment opportunity and asset management integration: Metric Rating Operational risks: Above Average Expected growth: Above Average Long term value creation: Excellent Positive competitive advantage: Excellent Management excellence: Average...

DISRUPTION AS OPPORTUNITY

Home Page

Podcast

Privacy Policy

Disclaimer

GDPR

Contact

Disclaimer

Past performance is not indicative of future results. This report presents historical data for the stated strategy, timeframe, and risk profile and reflects holdings as of the publication date; portfolio changes may have occurred since. Information is based on end-of-day data from sources believed to be reliable, but accuracy and completeness are not guaranteed. Prices reflect market values at the date of publication or the latest available data.

Investments involve risk, including potential loss of capital, particularly with leveraged strategies. Asset allocation and diversification do not guarantee profits or protect against losses, and investment suitability must be determined by each individual investor. Actual results may differ due to market conditions, taxes, fees, transaction costs, liquidity constraints, and risks including credit, interest rate, reinvestment, and liquidity risks. IX-7 Asset Management SA (IX-7) is a registered trademark, and all related logos, trademarks, product names, concepts, and materials are the exclusive property of IX-7 Asset Management SA. The full disclaimer is available here.